Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion type Assertion NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_head.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion description "[Another finding showed that flavopiridol treatment induced a substantial AKT-Ser473 phosphorylation in human glioblastoma T98G cell line in contrast to siRNA-mediated inhibition of Cdk9 and Cdk9 combined with Cdk7, whereas siRNA-mediated silencing of Cdk7 caused a minor increase in AKT-Ser473 phosphorylation.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion evidence source_evidence_literature NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion SIO_000772 22391209 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion wasDerivedFrom befree-2016 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.
- NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_assertion wasGeneratedBy ECO_0000203 NP965517.RAqbYY900UdgBxx1--1lxqWTqc3CSSGiVb-XnoNUmBIZ4130_provenance.